As of 2026-09-25, the Relative Valuation of Oncternal Therapeutics Inc (ONCT) is (249.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.53 USD, the upside of Oncternal Therapeutics Inc based on Relative Valuation is -47512.8%.
The range of the Relative Valuation is (225.44) - (293.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 25.1x | 22.2x |
| Forward P/E multiples | 15.9x - 25.2x | 20.6x |
| Fair Price | (225.44) - (293.19) | (249.68) |
| Upside | -42910.2% - -55775.4% | -47512.8% |
| Date | P/E |